Preventative Imaging Demand Highlighted by Prenuvo Early-Detection Data

According to a recent LinkedIn post from Prenuvo, the company highlights that 1 in 20 of its patients receives a high-risk finding from its whole-body imaging, with 2–2.5% reportedly diagnosed with cancer or an aneurysm, often without prior symptoms. The post references comments from CEO and founder Andrew Lacy, who is quoted emphasizing that feeling well does not necessarily equate to being healthy.

The LinkedIn post also points to an interview with The New York Post’s Lydia Moynihan, which explores how Prenuvo’s approach may be repositioning advanced imaging earlier in the care pathway rather than as a last resort. For investors, this emphasis on early detection and media visibility could signal growing demand for preventative imaging services and potentially support revenue growth if Prenuvo can scale its technology, manage clinical validation, and navigate reimbursement and regulatory considerations.